1. Guest, the 'News in Brief' for the week beginning 8th August 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Long-term SARS-CoV-2-specific immune & inflammatory responses in individuals recovering from COVID-19 with & without post-acute symptoms, 2021, Peluso

Discussion in 'Long Covid research' started by Andy, Aug 7, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    17,123
    Location:
    Hampshire, UK
    Highlights
    • The magnitude of early CD4+ T cell responses correlates with severity of COVID-19
    • Prior lung disease correlates with higher SARS-CoV-2-specific CD8+ T cell responses
    • PASC is associated with a decline in N-specific interferon-γ-producing CD8+ T cells
    • Neutralizing capacity correlates with SARS-CoV-2-specific CD4+ T cell responses
    Summary

    We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses, soluble markers of inflammation, and antibody levels and neutralization capacity longitudinally in 70 individuals with PCR-confirmed SARS-CoV-2 infection. Participants represent a spectrum of illness and recovery, including some with persistent viral shedding in saliva and many experiencing post-acute sequelae of SARS-CoV-2 infection (PASC). T cell responses remain stable for up to 9 months. Whereas the magnitude of early CD4+ T cell immune responses correlates with severity of initial infection, pre-existing lung disease is independently associated with higher long-term SARS-CoV-2-specific CD8+ T cell responses. Among participants with PASC 4 months following coronavirus disease 2019 (COVID-19) symptom onset, we observe a lower frequency of CD8+ T cells expressing CD107a, a marker of degranulation, in response to Nucleocapsid (N) peptide pool stimulation, and a more rapid decline in the frequency of N-specific interferon-γ-producing CD8+ T cells. Neutralizing antibody levels strongly correlate with SARS-CoV-2-specific CD4+ T cell responses.

    Open access, https://www.cell.com/cell-reports/fulltext/S2211-1247(21)00948-7
     

Share This Page